Latest News

Crude Heads for Worst Month in Six on Concern Worsening Global Trade Environment to Undermine Demand

Crude Heads for Worst Month in Six on Concern Worsening Global Trade Environment to Undermine Demand

Crude headed for the second week of declines in May as President Donald Trump’s threats to impose tariffs on Mexico, which is the largest recipient of US oil exports, added to concern that a worsening trade environment would undermine global energy demand. West Texas Intermediate crude futures fell by $1.94 intraday to $54.65, a 3.4% decline. Brent also fell, in […]

Zuora Touches Record Low After Guiding Q2, FY20 Revenue Below Street Views

Zuora Touches Record Low After Guiding Q2, FY20 Revenue Below Street Views

Zuora (ZUO) Thursday night announced a non-GAAP net loss of $0.11 per share for its Q1 ended April 30, improving on a $0.29 per share adjusted loss during the same quarter last year and beating the Capital IQ consensus looking for a $0.13 per share normalized net loss. Revenue grew 22% year over year to $64.1 million, matching the Street […]

Palomar Completes Reinsurance Renewal, First Placement of Specialty Homeowners Facility

Palomar Completes Reinsurance Renewal, First Placement of Specialty Homeowners Facility

Palomar Holdings (PLMR), a specialty property insurer, said it has completed the renewal of reinsurance programs that will take effect June 1. The company renewed $470 million of its core reinsurance program, which includes its catastrophe bond, and purchased $200 million of incremental limit. The company’s reinsurance program provides coverage up to $1.05 billion for earthquakes, which will enable Palomar […]

DelMar Pharma Shares Rally More Than 180% After Interim Trial Results of VAL-083 Update at ASCO

DelMar Pharma Shares Rally More Than 180% After Interim Trial Results of VAL-083 Update at ASCO

DelMar Pharmaceuticals (DMPI) shares rallied more than 180% on Friday after the company gave an encouraging update to its first- and second-line mid-stage trials of VAL-083 in patients with MGMT-unmethylated glioblastoma multiforme at the annual ASCO cancer meeting in Chicago. For the front-line treatment of the drug with radiation therapy, the trial showed eight patients getting a “complete response” and […]